Citation Impact
Citing Papers
Clinical guidelines on the management of hepatitis C
2001
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
2013
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Cancer Statistics, 2021
2021 Standout
Hepatocellular carcinoma
2003 Standout
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Liver fibrosis
2005 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Hepatitis C Virus Infection
2001 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?
2001
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
1999
Hepatitis B virus infection
2009 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Natural and iatrogenic variation in hepatitis B virus
1999
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Characterization of Liver T–Cell Receptor γδ+ T Cells Obtained From Individuals Chronically Infected With Hepatitis C Virus (Hcv): Evidence for These T Cells Playing A Role in the Liver Pathology Associated With Hcv Infections
2001 StandoutNobel
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
2007
HCV transmission in industrialized countries and resource-constrained areas
2013
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Adaptive Immunity to the Hepatitis C Virus
2010
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Hepatitis C Virus: Epidemiology, Transmission and Prevention
1998
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
2005 Standout
Risk factors of hepatitis C virus‐related liver cirrhosis in young adults: Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2) *0201 Allele
2001
Long-term follow-up after successful interferon therapy of acute hepatitis C
2004
The challenge of developing a vaccine against hepatitis C virus
2002
Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins
2004
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
PAML 4: Phylogenetic Analysis by Maximum Likelihood
2007 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years
2004
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus Infection
2003
Evaluation of automated RNA‐extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool‐screening systems
2000
Hepatitis E
2012
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Kinetics of the Immune Response During Hbv and Hcv Infection
2003
Limited humoral immunity in hepatitis C virus infection
1999
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
Response to cadmium in higher plants
1999 Standout
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E
2005
Paraformaldehyde protects of hepatitis C virus particles during ultracentrifugation
2001
Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil
1996
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
2001
Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy
1999
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Functional Role of Hepatitis C Virus Chimeric Glycoproteins in the Infectivity of Pseudotyped Virus
1998
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein
2005
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
2007
A method for detecting positive selection at single amino acid sites
1999
Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates
2004
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
2000 StandoutNobel
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus
1999 StandoutNobel
Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees
1999
Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo
2000 StandoutNobel
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
2001
Viral Quasispecies Evolution
2012
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
Structure-Function Analysis of Hepatitis C Virus Envelope-CD81 Binding
2000 StandoutNobel
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees
2000
Interferon-α for HBeAg-positive chronic hepatitis B
2003
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
2010
Dominant Role of Host Selective Pressure in Driving Hepatitis C Virus Evolution in Perinatal Infection
2000
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of H Meisel being referenced
Low dose alpha interferon treatment in chronic hepatitis B virus infection.
1993
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
1997
Accumulation and Persistence of Hepatitis B Virus Core Gene Deletion Mutants in Renal Transplant Patients Are Associated With End–Stage Liver Disease
1996
Behandlung der chronischen Hepatitis B mit Interferon α-2b
2008
Treatment of chronic hepatitis B with interferon alfa-2b
1990
Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation
2009
Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998
2001
Inhibition of hepatitis B virus DNA polymerase by 3′‐fluorothymidine triphosphate and other modified nucleoside triphosphate analogs
1990
Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin
1995
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients
1995
Rational use of diagnostic tools in hepatitis C.
1996
Detection of hantaviruses by polymerase chain reaction
1996
Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease
1996
Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogs
1991
Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus
1997